miR-21 and miR-145 as Prognostic Biomarkers for Radiotherapy Responses in Cervical Cancer Patients: A Preliminary Study
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910545 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Andi D Putra und 8 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program in Medical Sciences, Faculty of Medicine, Universitas Indonesia, Central Jakarta 10430, Indonesia. Hauptthemen laut MEDLINE: MicroRNAs, Uterine Cervical Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Radioresistance poses a significant challenge in the effective treatment of cervical cancer, often leading to poor patient outcomes. MicroRNA-21 (miR-21) and MicroRNA-145 (miR-145) are oncogenic micro-RNAs associated with various cancers, including cervical cancer, but their potential as predictive biomarkers for radioresistance remains underexplored. This study aimed to investigate the association between miR-21 and miR-145 expressions and the response to radiation therapy in cervical cancer patients. An analytical cross-sectional study was conducted on 140 subjects with cervical cancer stages IIIB and IVA who received definitive radiotherapy. miR-21 and miR-145 expressions were measured using real-time reverse transcriptase–polymerase chain reaction (RT-qPCR). A total of 102 subjects (72.9%) were classified as having stage III cervical cancer, and 38 subjects (27.1%) were classified as having stage IV cervical cancer. Disease progression occurred in 60.7% of subjects. The cut-off value for miR-21 expression was 0.00088 nmol/(mg/mL) (AUC 0.676, sensitivity 70.8%, specificity 50.8%), and a higher expression was significantly associated with radioresistance (p = 0.010). miR-145, with a cut-off of 0.0239 nmol/(mg/mL) (AUC 0.612, sensitivity 67.5%, specificity 45.5%), showed no significant association with treatment response (p = 0.132). Combining miR-21 and miR-145 (AUC 0.639, sensitivity 68.6%, specificity 46.9%, p = 0.063) did not significantly improve the predictive accuracy. This study suggests that an elevated miR-21 expression is significantly associated with radioresistance in cervical cancer patients, while miR-145 expression shows no significant correlation with treatment response. Additionally, combining miR-21 and miR-145 does not enhance the predictive power.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral Program in Medical Sciences, Faculty of Medicine, Universitas Indonesia, Central Jakarta 10430, Indonesia.
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Central Jakarta 10430, Indonesia.
- Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Central Jakarta 10430, Indonesia.
- Department of Anatomical Pathology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Central Jakarta 10430, Indonesia.
- Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Central Jakarta 10310, Indonesia.
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin Hospital, Bandung 40161, Indonesia.
ORCID-Profile: Hariyono Winarto, Jourdan Wirasugianto
Zitieren
APA
Putra, A. D., Andrijono, Winarto, H., Prijanti, A. R., Rachmadi, L., Pakasi, T. A., Gandamihardja, S., Wirasugianto, J., & Amelia (2024). miR-21 and miR-145 as Prognostic Biomarkers for Radiotherapy Responses in Cervical Cancer Patients: A Preliminary Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910545
Vancouver
Putra AD, Andrijono, Winarto H, Prijanti AR, Rachmadi L, Pakasi TA, et al. miR-21 and miR-145 as Prognostic Biomarkers for Radiotherapy Responses in Cervical Cancer Patients: A Preliminary Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910545
BibTeX
@article{Putra2024,
author = {Putra, Andi D and Andrijono and Winarto, Hariyono and Prijanti, Ani R and Rachmadi, Lisnawati and Pakasi, Trevino A and Gandamihardja, Supriadi and Wirasugianto, Jourdan and Amelia},
title = {miR-21 and miR-145 as Prognostic Biomarkers for Radiotherapy Responses in Cervical Cancer Patients: A Preliminary Study},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910545}
}
EUVIMED